Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Susana N Banerjee; Els Van Nieuwenhuysen; Carol Aghajanian; Véronique D'Hondt; Bradley J Monk; Andrew Clamp; Emily Prendergast; Ana Oaknin; Kari Ring; Nicoletta Colombo; Robert W Holloway; Manuel Rodrigues; Hye Sook Chon; Charlie Gourley; Alessandro D Santin; Premal H Thaker; Christine Gennigens; Gregg Newman; Erin Salinas; Hagop Youssoufian; Kathleen N Moore; Stephanie Lustgarten; David M O'Malley; Toon Van Gorp; Rachel N Grisham

doi:10.1200/JCO-25-02377

Back

Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Journal article

Peer reviewed

Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D'Hondt, Bradley J Monk, Andrew Clamp, Emily Prendergast, Ana Oaknin, Kari Ring, Nicoletta Colombo, …

Journal of clinical oncology, p.JCO2502377

10/13/2025

DOI: https://doi.org/10.1200/JCO-25-02377

PMID: 41082694

Metrics

2 Record Views

Details

Title: Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Creators: Susana N Banerjee
Els Van Nieuwenhuysen
Carol Aghajanian
Véronique D'Hondt
Bradley J Monk
Andrew Clamp
Emily Prendergast
Ana Oaknin
Kari Ring
Nicoletta Colombo
Robert W Holloway
Manuel Rodrigues
Hye Sook Chon
Charlie Gourley
Alessandro D Santin
Premal H Thaker
Christine Gennigens
Gregg Newman
Erin Salinas
Hagop Youssoufian
Kathleen N Moore
Stephanie Lustgarten
David M O'Malley
Toon Van Gorp
Rachel N Grisham
Publication Details: Journal of clinical oncology, p.JCO2502377
Identifiers: 991006227264502656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article

Erratum: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Related links

Metrics

Details